1983
DOI: 10.1016/0026-0495(83)90045-8
|View full text |Cite
|
Sign up to set email alerts
|

Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0
2

Year Published

1986
1986
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 122 publications
(39 citation statements)
references
References 17 publications
1
36
0
2
Order By: Relevance
“…Elevations in levels of serum homocysteine have been consistently demonstrated in patients with coronary and cerebrovascular disease, while discrete hyperhomocysteinaemia has been associated with increased risk for both myocardial infarction and stroke (Wilcken et al 1983 ;Ueland et al 1992 ;Boers, 1994). Although a variety of conditions may result in raised homocysteine, the link with vascular disease appears to remain constant.…”
Section: Identifying Genetically-determined Risk Factorsmentioning
confidence: 99%
“…Elevations in levels of serum homocysteine have been consistently demonstrated in patients with coronary and cerebrovascular disease, while discrete hyperhomocysteinaemia has been associated with increased risk for both myocardial infarction and stroke (Wilcken et al 1983 ;Ueland et al 1992 ;Boers, 1994). Although a variety of conditions may result in raised homocysteine, the link with vascular disease appears to remain constant.…”
Section: Identifying Genetically-determined Risk Factorsmentioning
confidence: 99%
“…Once formed homocysteine is either transsulfurated by cystathionine-β-synthase or remethylated by methylene tetrahydrofolate reductase (10). Cystathionine-β-synthase is deficient totally in homocysteinuria and partially in its carrier state, leading to high levels of homocyteine (11). Methylene tetrahydrofolate reductase requires vitamins B6, B12 and folate as co-factors (10).…”
Section: Introductionmentioning
confidence: 99%
“…However, partially impaired transsulfuration in heterozygotes for CBS deficiency is often not associated with elevated fasting plasma tHcy concentrations (26)(27)(28). When the transsulfuration pathway is stressed by an oral l -methionine load test, it is sometimes possible to differentiate between heterozygotes and controls by the higher postmethionine load plasma tHcy concentrations in the former group (27,28).…”
Section: Introductionmentioning
confidence: 99%
“…However, partially impaired transsulfuration in heterozygotes for CBS deficiency is often not associated with elevated fasting plasma tHcy concentrations (26)(27)(28). When the transsulfuration pathway is stressed by an oral l -methionine load test, it is sometimes possible to differentiate between heterozygotes and controls by the higher postmethionine load plasma tHcy concentrations in the former group (27,28). In addition, changes in vitamin B-6 status do not affect fasting plasma tHcy concentrations (29,30), while high dose pyridoxine supplementation has been shown to attenuate the post-methionine load plasma tHcy concentrations (31,32).…”
Section: Introductionmentioning
confidence: 99%